Estimated delivery in United States, on Thursday 5 Dec 2024
Product Information
Name:
Adefovir Dipivoxil
Controlled Product
Synonyms:
- 1,1'-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)] 2,2-dimethyl-Propanoic acid ester
- Propanoic acid
- 2,2-dimethyl-
- [[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene) ester (9CI)
- GS 0840
- Hepsera
- Preveon
- bis(POM)-PMEA
- 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate
- 9-[2-[Bis[(Pivaloyloxy)Methoxy]Phosphinyl]Methoxy]Ethyl]Adenine
- See more synonyms
- Adefovir Dipivoxl
- Adefovir Pivoxil
- Adefovir dipivoxil
- Gs 0840
- Propanoic acid, 2,2-dimethyl-, 1,1′-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)] ester
- Propanoic acid, 2,2-dimethyl-, [[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene) ester
- [2-(6-Aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Mikromol
Long term storage:
Notes:
Chemical properties
Molecular weight:
501.47
Formula:
C20H32N5O8P
Color/Form:
Off-White
InChI:
InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)
InChI key:
InChIKey=WOZSCQDILHKSGG-UHFFFAOYSA-N
SMILES:
CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 86-MM3505.00 Adefovir Dipivoxil
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
